What's new

Orphan designation: human IgG1 monoclonal antibody against sortilin Treatment of frontotemporal dementia, 15/10/2021 Positive

Orphan designation: human IgG1 monoclonal antibody against sortilin Treatment of frontotemporal dementia, 15/10/2021 Positive

Jun 10, 2025 - 08:25
 0
Orphan designation: human IgG1 monoclonal antibody against sortilin Treatment of frontotemporal dementia, 15/10/2021 Positive
Orphan designation: human IgG1 monoclonal antibody against sortilin Treatment of frontotemporal dementia, 15/10/2021 Positive
Read More

Tags:

Previous Article

Orphan designation: Synthetic oligonucleotide selectively targeting UBE3A antise...

Next Article

Orphan designation: Entospletinib Treatment of acute myeloid leukaemia, 16/10/20...

Related Posts

Annexes - 2024 annual report of the European Medicines ...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 22, 2025  0

Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0